Exemestane

  (EK-seh-MEH-stayn)

This page contains brief information about exemestane and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s):		Aromasin
FDA Approved:		Yes

FDA Approval for Exemestane

Exemestane is approved to treat:

• Breast cancer that is advanced.

• Breast cancer that is early-stage and estrogen receptor positive.

Exemestane is used in postmenopausal women who have already been treated with tamoxifen citrate.

Exemestane is also being studied in the treatment of other types of cancer.

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Exemestane - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Hormone Therapy for Breast Cancer - Information about the use of this drug to prevent and treat cancer.

Targeted Cancer Therapies - Information about the use of this drug to treat cancer.

Clinical Trial Results: Exemestane Following Tamoxifen Reduces Breast Cancer Recurrences and Prolongs Survival - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Combination Therapy Shows Promise for Treating Advanced Breast Cancer - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Exemestane Substantially Reduces Breast Cancer Risk - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Study Confirms Risk of Bone Loss for Patients Taking Exemestane - Important clinical trial results for this drug, background information, and how the trial was done.

Find Clinical Trials for Exemestane - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Back to Top